Incyte to Report First Quarter Financial Results
April 11 2024 - 8:00AM
Business Wire
Incyte (Nasdaq:INCY) announced today that it has scheduled its
first quarter financial results conference call and webcast for
8:00 a.m. ET on Tuesday, April 30, 2024.
The schedule for the press release and conference call/webcast is
as follows:
• Q1 2024 Press Release:
April 30, 2024 at 7:00 a.m. ET
• Q1 2024 Conference Call:
April 30, 2024 at 8:00 a.m.
ET
• Domestic Dial-In Number:
877-407-3042
• International Dial-In Number: 201-389-0864
•
Conference ID Number: 13745743
If you are unable to participate, a replay of the conference
call will be available for thirty days. The replay dial-in number
for the U.S. is 877-660-6853 and the dial-in number for
international callers is 201-612-7415. To access the replay
you will need the conference ID number 13745743.
The live webcast with slides can be accessed at
Investor.Incyte.com and will be available for replay for ninety
days.
About Incyte
A global biopharmaceutical company on a mission to Solve On.,
Incyte follows the science to find solutions for patients with
unmet medical needs. Through the discovery, development and
commercialization of proprietary therapeutics, Incyte has
established a portfolio of first-in-class medicines for patients
and a strong pipeline of products in Oncology and Inflammation
& Autoimmunity. Headquartered in Wilmington, Delaware, Incyte
has operations in North America, Europe and Asia.
For additional information on Incyte, please visit Incyte.com or
follow us on social media: LinkedIn, X, Instagram, Facebook,
YouTube.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240411369652/en/
Media media@incyte.com
Investors ir@incyte.com
Incyte (NASDAQ:INCY)
Historical Stock Chart
From Jul 2024 to Jul 2024
Incyte (NASDAQ:INCY)
Historical Stock Chart
From Jul 2023 to Jul 2024